![[Feature stock] HLB price rises to upper limit on expectations of resolution of US approval issue for liver cancer new drug](https://img.yna.co.kr/photo/cms/2023/10/28/04/PCM20231028000004017_P2.jpg)
[Feature stock] HLB price rises to upper limit on expectations of resolution of US approval issue for liver cancer new drug
⚡ Quick Summary
(Seoul = Yonhap News) Reporter Lee Min-young = As HLB announced that most of the problems in the U.S.
(Seoul = Yonhap News) Reporter Lee Min-young = As HLB announced that most of the problems in the U.S. approval process for a liver cancer new drug have been resolved, the group's stock price rose on the 15th...
📰 Related Articles
Chinese Communist Party theorist Wang Huning visits North Korea... North Korea and China close strategic cooperation
Khan
‘Abolishment of supplementary investigation rights’ Park Ji-won turns to “let’s make exceptions within the scope of helping the weak”… Democratic Party leaders “We have never voted for abolition”
Khan
SM Bexel begins full-scale development of batteries for next-generation drones and robots
Khan